The largest database of trusted experimental protocols

Pf 01247324

Manufactured by Merck Group
Sourced in Germany

PF-01247324 is a laboratory equipment product manufactured by Merck Group. It is designed for use in various research and analytical applications. The core function of this product is to facilitate accurate and precise measurements and data collection.

Automatically generated - may contain errors

6 protocols using pf 01247324

1

Patch-Clamp Analysis of iPSC-Derived Cardiomyocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
The patch-clamp experiments was performed as previously described [19 (link),22 (link)]. Briefly, 35,000 atrial iPSC-CMs were plated on glass-bottom Fluoro Dishes and incubated with either isoproterenol (50 nmol/L, Sigma-Aldrich, Taufkirchen, Germany)) or isoproterenol + PF01247324 (1 µmol/L, Sigma-Aldrich, Taufkirchen, Germany)) for 15 min before starting the measurements. The experiments were conducted at room temperature.
Action potential recordings were performed using the whole-cell patch-clamp technique. To elicit action potentials, square current pulses with amplitudes of 0.5–1 nA and durations of 1–5 ms were applied. The stimulation frequency was increased gradually from 0.5 to 2 Hz.
The late sodium current (INaL) was measured using the ruptured-patch whole-cell patch-clamp technique. The pipette used had a resistance ranging from 2 to 3 mega-ohms (MΩ). INaL recordings were performed exclusively in CMs where a seal with a resistance of over 1 giga-ohm (GΩ) was achieved, and the access resistance remained below 7 MΩ. After a stabilization period of 3 min, the iPSC-derived CMs were held at a holding potential of −120 mV and then depolarized to −35 mV for 1000 ms with 10 pulses and a basic cycle length of 2 s. The INaL was quantified as the integral current amplitude between 100 and 500 ms and was normalized to the membrane capacitance.
+ Open protocol
+ Expand
2

Reagent Preparation for Biochemical Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
KCl (131494; Panreac-AppliChem, Castellar del Vallès, Barcelona, Spain), CaCl2 (22320.298; VWR, Llinars del Vallès, Barcelona, Spain), and NaCl (S9888; Sigma–Aldrich, Madrid, Spain) were freshly weighed and dissolved before each assay. Thapsigargin (T9033; Sigma–Aldrich), PF-01247324 (PZ0274; Sigma-Aldrich), BIII 890CL (Boehringer Ingelheim, Sant Cugat del Vallès, Barcelona, Spain) and BIII-55CL (Boehringer Ingelheim) were diluted in DMSO (dimethyl sulfoxide; D8418; Sigma–Aldrich) at a stock concentration of 10 mM and stored at –20°C. Tetrodotoxin citrate (T-550; Alomone Labs, Jerusalem, Israel) was diluted in water at a stock concentration of 1 mM and stored at –20°C.
+ Open protocol
+ Expand
3

Selective Inhibition of NaV1.8 Currents

Check if the same lab product or an alternative is used in the 5 most similar protocols
For selective inhibition of NaV1.8-induced sodium currents, a specific NaV1.8 blocker PF-01247324 (1 µmol/L, Sigma-Aldrich, Taufkirchen, Germany)) was used. Cellular electrophysiological measurements were performed under slight beta-adrenergic stimulation (isoproterenol (Iso), 50 nmol/L, Sigma-Aldrich, Taufkirchen, Germany)) [20 (link)]. Prior to the start of experiments, the CMs were incubated for 15 min with both substances or isoproterenol alone as a control.
+ Open protocol
+ Expand
4

Sodium Current Measurement in Mouse Cardiomyocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Ruptured-patch whole-cell voltage-clamp was used to measure INa in mouse cardiomyocytes with microelectrodes (2–3 MΩ, room temperature). Pipettes were filled with (in mmol/L): 80 CsCl, 40 Cs-glutamate, 5 NaCl, 0.92 MgCl2, 5 Mg-ATP, 0.3 Li-GTP, 5 HEPES, 0.03 niflumic acid (to block Ca2+-activated chloride current), 0.02 nifedipine (to block Ca2+ current), 0.004 strophanthidin (to block Na+/K+ ATPase current), 1 EGTA, and 0.36 CaCl2 (free [Ca2+]i,100 nmol/L) (pH 7.2 with CsOH at room temperature). Cardiomyocytes were maintained in the bath solution containing (in mmol/L): 5 NaCl, 135 tetramethylammonium chloride, 4 CsCl, 2 MgCl2, 10 glucose, 10 HEPES, 0.4 CaCl2 (pH 7.4 with KOH at room temperature). INa was measured only in those cardiomyocytes where a seal of more than 1 Giga-Ohm was achieved and the access resistance remained <7 MΩ. Mouse cardiomyocytes were incubated with PF-01247324 (1 µmol/L, Sigma) for 15 min before starting INa measurements. In all experiments, myocytes were mounted on the stage of a microscope (Nikon Eclipse TE2000-U). Liquid junction potentials were corrected with the pipette in the bath. Membrane capacitance and series resistance were compensated after patch rupture. Data were collected using Patchmaster 2.0 (HEKA Elektronik).
+ Open protocol
+ Expand
5

Measurement of Persistent Sodium Current

Check if the same lab product or an alternative is used in the 5 most similar protocols
Ruptured whole-cell patch-clamp experiments were applied to establish the current–voltage relationship of INaL. The pipette resistance ranged between 1.5 and 3.5 MΩ when filled with the pipette solution containing (in mmol/L): 95 CsCl, 40 Cs-glutamate, 10 NaCl, 0.92 MgCl2, 5 Mg- ATP, 0.3 Li-GTP, 5 HEPES, 0.03 niflumic acid (to block Ca2+-activated chloride current), 0.02 nifedipine (to block Ca2+ current), 0.004 strophanthidin (to block Na+/K+ ATPase current), 1 EGTA, and 0.36 CaCl2 (free [Ca2+]i,100 nmol/L) (pH 7.2 with CsOH at room temperature). The bath solution contained (in mmol/L): 135 NaCl, 5 tetramethylammonium chloride, 4 CsCl, 2 MgCl2, 10 glucose, 10 HEPES (pH 7.4 with CsOH at room temperature). In some experiments, cardiomyocytes were incubated with PF-01247324 (1 μmol/L, Sigma) for 15 min before initiation of INaL measurements. After patch rupture cardiomyocytes were allowed to stabilize for at least 3 min. Currents were elicited using a voltage step protocol with 10 mV increments ranging from −120 to +30 mV (step duration: 1 s, holding potential: −120 mV). INaL was determined as the mean current density between 180 to 190 ms of each depolarization step. PF-sensitive INaL was calculated as the difference between the mean INaL densities of the vehicle and PF-treated cardiomyocytes at each membrane potential.
+ Open protocol
+ Expand
6

Selective Blockade of Nav1.8 in Cardiomyocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
For selectively blocking NaV1.8, isolated cardiomyocytes were treated with either A-803467 (30 nmol/L, Sigma) or PF-01247324 (1 µmol/L, Sigma). Cells were incubated for 15 min before measurements were started. Isoproterenol (30 nmol/L, Sigma) was used for slight beta-adrenergic stimulation in all groups [10 (link)]. Moreover, we used tetrodotoxin (2 µmol/l) to inhibit INaL.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!